API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
0
Uploaded Dossiers
U.S. Medicaid
0
Annual Reports
0
81
PharmaCompass offers a list of Dimenhydrinate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dimenhydrinate manufacturer or Dimenhydrinate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dimenhydrinate manufacturer or Dimenhydrinate supplier.
PharmaCompass also assists you with knowing the Dimenhydrinate API Price utilized in the formulation of products. Dimenhydrinate API Price is not always fixed or binding as the Dimenhydrinate Price is obtained through a variety of data sources. The Dimenhydrinate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Dimenhydrinate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dimenhydrinate, including repackagers and relabelers. The FDA regulates Dimenhydrinate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dimenhydrinate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dimenhydrinate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dimenhydrinate supplier is an individual or a company that provides Dimenhydrinate active pharmaceutical ingredient (API) or Dimenhydrinate finished formulations upon request. The Dimenhydrinate suppliers may include Dimenhydrinate API manufacturers, exporters, distributors and traders.
click here to find a list of Dimenhydrinate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Dimenhydrinate DMF (Drug Master File) is a document detailing the whole manufacturing process of Dimenhydrinate active pharmaceutical ingredient (API) in detail. Different forms of Dimenhydrinate DMFs exist exist since differing nations have different regulations, such as Dimenhydrinate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Dimenhydrinate DMF submitted to regulatory agencies in the US is known as a USDMF. Dimenhydrinate USDMF includes data on Dimenhydrinate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Dimenhydrinate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Dimenhydrinate suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Dimenhydrinate Drug Master File in Japan (Dimenhydrinate JDMF) empowers Dimenhydrinate API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Dimenhydrinate JDMF during the approval evaluation for pharmaceutical products. At the time of Dimenhydrinate JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Dimenhydrinate suppliers with JDMF on PharmaCompass.
A Dimenhydrinate CEP of the European Pharmacopoeia monograph is often referred to as a Dimenhydrinate Certificate of Suitability (COS). The purpose of a Dimenhydrinate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Dimenhydrinate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Dimenhydrinate to their clients by showing that a Dimenhydrinate CEP has been issued for it. The manufacturer submits a Dimenhydrinate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Dimenhydrinate CEP holder for the record. Additionally, the data presented in the Dimenhydrinate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Dimenhydrinate DMF.
A Dimenhydrinate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Dimenhydrinate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Dimenhydrinate suppliers with CEP (COS) on PharmaCompass.
A Dimenhydrinate written confirmation (Dimenhydrinate WC) is an official document issued by a regulatory agency to a Dimenhydrinate manufacturer, verifying that the manufacturing facility of a Dimenhydrinate active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Dimenhydrinate APIs or Dimenhydrinate finished pharmaceutical products to another nation, regulatory agencies frequently require a Dimenhydrinate WC (written confirmation) as part of the regulatory process.
click here to find a list of Dimenhydrinate suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dimenhydrinate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dimenhydrinate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dimenhydrinate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dimenhydrinate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dimenhydrinate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dimenhydrinate suppliers with NDC on PharmaCompass.
Dimenhydrinate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Dimenhydrinate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Dimenhydrinate GMP manufacturer or Dimenhydrinate GMP API supplier for your needs.
A Dimenhydrinate CoA (Certificate of Analysis) is a formal document that attests to Dimenhydrinate's compliance with Dimenhydrinate specifications and serves as a tool for batch-level quality control.
Dimenhydrinate CoA mostly includes findings from lab analyses of a specific batch. For each Dimenhydrinate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Dimenhydrinate may be tested according to a variety of international standards, such as European Pharmacopoeia (Dimenhydrinate EP), Dimenhydrinate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Dimenhydrinate USP).